Dynamic interactions and Ca2+-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seeding

• Published in: Nature communications 2021-11, Vol.12 (1), p.6292-6292, Article 6292
• Main Authors: Moreira, Guilherme G., Cantrelle, François-Xavier, Quezada, Andrea, Carvalho, Filipa S., Cristóvão, Joana S., Sengupta, Urmi, Puangmalai, Nicha, Carapeto, Ana P., Rodrigues, Mário S., Cardoso, Isabel, Fritz, Güenter, Herrera, Federico, Kayed, Rakez, Landrieu, Isabelle, Gomes, Cláudio M.
• Format: Article
• Language: English
• Subjects: 14; 631/45/470; 631/45/535; 631/45/56; Agglomeration; Amyloid; Biochemistry; Biochemistry, Molecular Biology; Calcium ions; Calcium-binding protein; Chemical kinetics; Dimers; Fibrils; Humanities and Social Sciences; Inclusions; Inflammation; Life Sciences; Metal ions; multidisciplinary; Neurodegenerative diseases; NMR; Nuclear magnetic resonance; Nucleation; Oligomers; Proteins; Reaction kinetics; S100b protein; Science; Science (multidisciplinary); Structural analysis; Structural Biology; Tau protein; Toxicity
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-021-26584-2

The microtubule-associated protein tau is implicated in the formation of oligomers and fibrillar aggregates that evade proteostasis control and spread from cell-to-cell. Tau pathology is accompanied by sustained neuroinflammation and, while the release of alarmin mediators aggravates disease at late stages, early inflammatory responses encompass protective functions. This is the case of the Ca 2+ -binding S100B protein, an astrocytic alarmin which is augmented in AD and which has been recently implicated as a proteostasis regulator, acting over amyloid β aggregation. Here we report the activity of S100B as a suppressor of tau aggregation and seeding, operating at sub-stoichiometric conditions. We show that S100B interacts with tau in living cells even in microtubule-destabilizing conditions. Structural analysis revealed that tau undergoes dynamic interactions with S100B, in a Ca 2+ -dependent manner, notably with the aggregation prone repeat segments at the microtubule binding regions. This interaction involves contacts of tau with a cleft formed at the interface of the S100B dimer. Kinetic and mechanistic analysis revealed that S100B inhibits the aggregation of both full-length tau and of the microtubule binding domain, and that this proceeds through effects over primary and secondary nucleation, as confirmed by seeding assays and direct observation of S100B binding to tau oligomers and fibrils. In agreement with a role as an extracellular chaperone and its accumulation near tau positive inclusions, we show that S100B blocks proteopathic tau seeding. Together, our findings establish tau as a client of the S100B chaperone, providing evidence for neuro-protective functions of this inflammatory mediator across different tauopathies. The calcium binding protein S100B is an abundantly expressed protein in the brain and has neuro-protective functions by inhibiting Aβ aggregation and metal ion toxicity. Here, the authors combine cell biology and biochemical experiments with chemical kinetics and NMR measurements and show that S100B protein is an extracellular Tau chaperone and further characterize the interactions between S100B and Tau.